114 related articles for article (PubMed ID: 6584932)
1. Prolactin response to single and multiple doses of haloperidol in schizophrenic patients.
Ravichandran GK; Lu RB; Shvartsburd A; Misra CH; Ho BT; Kahn M; Smith RC
Psychiatry Res; 1984 Jan; 11(1):61-9. PubMed ID: 6584932
[TBL] [Abstract][Full Text] [Related]
2. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
[TBL] [Abstract][Full Text] [Related]
3. Determination of plasma haloperidol concentrations by radioreceptor assay in schizophrenia: clinical utility.
Santos JL; Ramos JA; Prieto P; Almoguera I; Vazquez C; Rubio ME; Cabranes JA
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):917-25. PubMed ID: 2813809
[TBL] [Abstract][Full Text] [Related]
4. Serum prolactin as a correlate of clinical response to haloperidol.
Van Putten T; Marder SR; Mintz J
J Clin Psychopharmacol; 1991 Dec; 11(6):357-61. PubMed ID: 1770154
[TBL] [Abstract][Full Text] [Related]
5. Prolactin bioassay in schizophrenia before and after neuroleptics.
Peabody CA; Warner MD; Griffin M; Boutros NN; Worsley IG; Friesen HG
Psychiatry Res; 1992 Mar; 41(3):249-55. PubMed ID: 1594711
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.
Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M
Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731
[TBL] [Abstract][Full Text] [Related]
7. The relationship between prolactin levels and clinical ratings in manic patients treated with oral and intravenous test doses of haloperidol.
Cookson JC; Moult PJ; Wiles D; Besser GM
Psychol Med; 1983 May; 13(2):279-85. PubMed ID: 6878514
[TBL] [Abstract][Full Text] [Related]
8. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
Rao ML; Brown WA
Psychopharmacology (Berl); 1987; 93(2):237-42. PubMed ID: 2892222
[TBL] [Abstract][Full Text] [Related]
9. Prolactin response to low-dose haloperidol challenge in schizophrenic, non-schizophrenic psychotic, and control subjects.
Copolov DL; Keks NA; Kulkarni J; Singh BS; McKenzie D; McGorry P; Hill C
Psychoneuroendocrinology; 1990; 15(3):225-31. PubMed ID: 2255750
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic radioreceptor activity and clinical outcome in schizophrenia.
Contreras S; Alexander H; Faber R; Bowden C
J Clin Psychopharmacol; 1987 Apr; 7(2):95-8. PubMed ID: 3584527
[TBL] [Abstract][Full Text] [Related]
11. Serum haloperidol determinations in psychiatric patients. Comparison of methods and correlation with serum prolactin level.
Rubin RT; Forsman A; Heykants J; Ohman R; Tower B; Michiels M
Arch Gen Psychiatry; 1980 Sep; 37(9):1069-74. PubMed ID: 7416906
[TBL] [Abstract][Full Text] [Related]
12. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
Turbott J; Villiger J; Hunter L
Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373
[TBL] [Abstract][Full Text] [Related]
13. [Standard and high doses of haloperidol. Clinical, pharmacokinetic and pharmacodynamic aspects].
Schilkrut R; Haverbeck C; Duran E; Delgado S; Kohen P; Birkner R; Katz I
Acta Psiquiatr Psicol Am Lat; 1981; 27(4-5):315-24. PubMed ID: 7348089
[TBL] [Abstract][Full Text] [Related]
14. Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder.
Chou JC; Douyon R; Czobor P; Volavka J; Cooper TB
Psychiatry Res; 1998 Oct; 81(1):51-5. PubMed ID: 9829650
[TBL] [Abstract][Full Text] [Related]
15. Effects of treatment with various doses of haloperidol on the pituitary-gonadal axis in male schizophrenic patients.
Rinieris P; Hatzimanolis J; Markianos M; Stefanis C
Neuropsychobiology; 1989; 22(3):146-9. PubMed ID: 2485861
[TBL] [Abstract][Full Text] [Related]
16. Effect of propranolol treatment on serum prolactin level in schizophrenic patients.
Elizur A; Segal Z; Yeret A; Ben-David M
Commun Psychopharmacol; 1980; 4(3):203-6. PubMed ID: 7226751
[No Abstract] [Full Text] [Related]
17. Relationship of butaperazine blood levels to plasma prolactin in chronic schizophrenic patients.
Smith RC; Tamminga CA; Crayton JW; Dekirmenjian H; Davis JM
Psychopharmacology (Berl); 1979; 66(1):29-33. PubMed ID: 44374
[TBL] [Abstract][Full Text] [Related]
18. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
Chouinard G; Safadi G; Beauclair L
J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
[TBL] [Abstract][Full Text] [Related]
19. Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia.
Rao VA; Bishop M; Coppen A
Br J Psychiatry; 1980 Dec; 137():518-21. PubMed ID: 7214106
[TBL] [Abstract][Full Text] [Related]
20. Prolactin response to bromperidol treatment in schizophrenic patients.
Yasui N; Kondo T; Otani K; Ishida M; Mihara K; Suzuki A; Kaneko S; Inoue Y
Pharmacol Toxicol; 1998 Mar; 82(3):153-6. PubMed ID: 9553995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
